On Thursday, Sequenom, Inc. (NASDAQ:SQNM)’s shares declined -16.67% to $2.35.
Sequenom, Inc. (SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, stated total revenues of $32.8 million for the second quarter of 2015, a decrease of 18% contrast to revenues of $39.8 million for the second quarter of 2014. Revenues for the second quarter of 2014 comprised of about $6.1 million of incremental “catch-up” payments from payors for services performed in preceding periods, in addition to the incremental change for the conversion from cash to accrual accounting for certain payors. No noteworthycatch-up collections were received in the second quarter of 2015, as the timeliness of collections has improved with additional payor contracts. Sequenom now has coverage for 172 million commercial lives and 40 million lives under Medicaid programs. The second quarter of 2015 had lower diagnostic services revenues contrast to the second quarter of 2014 by about $3 million, associated with the conversion of a referring laboratory partner to a patent pool licensee.
License revenues raised to $1.9 million for the second quarter of 2015, contrast to $0.4 million for the second quarter of 2014, reflecting the enhance in test fees under the Pooled Patents Agreement that was signed in December 2014.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally. The company provides molecular based laboratory developed tests (LDTs) comprising MaterniT21 PLUS LDT, a noninvasive prenatal test (NIPT) to detect fetal chromosomal abnormalities; HerediT CF LDT, a carrier screen test to identify individuals with cystic fibrosis or genetic mutations; SensiGene fetal Rhesus D (RhD) LDT, a NIPT to determine the presence or absence of RhD factor by direct detection of the fetal RhD genotype in RhD negative mothers from a maternal blood sample; and VisibiliT LDT, a NIPT to detect fetal chromosomal abnormalities by determining the relative amount of chromosomal material present in circulating cell-free DNA in a maternal blood sample.
Huntington Bancshares Incorporated (NASDAQ:HBAN)’s shares dropped -0.34% to $11.73.
Huntington Bancshares Incorporated (HBAN) declared the release of its mid-cycle, company-run capital stress test results as required by the Dodd-Frank Act. Results can be found on Huntington’s Investor Relations website under the heading “Publications and Filings” (http://huntington-ir.com/main/Regulatory.htm). Results are based on a forward-looking exercise using hypothetical severely adverse macroeconomic assumptions developed by Huntington.
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services. The company’s Retail and Business Banking segment offers financial products and services, counting checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans, and small business loans; and investments, insurance, interest rate risk protection, foreign exchange hedging, and treasury administration services.
At the end of Thursday’s trade, Nielsen NV (NYSE:NLSN)‘s shares dipped -3.12% to $46.55.
The Conference Board Consumer Confidence Index®, which had improved in June, declined in July. The Index now stands at 90.9 (1985=100), down from 99.8 in June. The Present Situation Index reduced moderately from 110.3 last month to 107.4 in July, while the Expectations Index declined sharply to 79.9 from 92.8 in June.
The monthly Consumer Confidence Survey®, based on a probability-design random sample, is conducted for The Conference Board by Nielsen, a leading global provider of information and analytics around what consumers buy and watch. The cutoff date for the preliminary results was July 16.
Nielsen N.V. operates as an information and measurement company. The company provides media and marketing information, analytics, and manufacturer and retailer expertise about what and where consumers buy, read, watch and listen. Its Buy segment provides data on retail measurement services, such as market share and competitive sales volumes; insights into distribution, pricing, merchandising, and promotion; consumer panel measurement, which offers insight into shopper behavior and customer segmentation; and consumer intelligence and analytical services for decision making in development and marketing cycles.
Time Warner Cable Inc (NYSE:TWC), ended its Thursday’s trading session with -0.67% loss, and closed at $190.22.
Time Warner Cable Inc. (TWC) stated financial results for its second quarter ended June 30, 2015.
HIGHLIGHTS
Financial Highlights
- Second-quarter 2015 revenue grew 3.5% year over year with Business Services revenue up 16.2% and Residential Services revenue up 2.1%.
- Second-quarter Adjusted OIBDA was $2.0 billion – a 1.2% decrease year over year as a result of continued aggressive investments, in addition to higher programming costs and pension expense. Not taking into account the $27 million enhance in pension expense, Adjusted OIBDA would have been flat.
- Higher depreciation expense from “TWC Maxx” and other investments also reduced second-quarter Operating Income to $1.0 billion.
Time Warner Cable Inc., together with its auxiliaries, provides video, high-speed data, and voice services in the United States. It operates in three segments: Residential Services, Business Services, and Other Operations. The Residential Services segment offers video services, counting video on demand, digital video recorder, and start over and look back services; high-speed data services that comprise communication tools and personalized services, such as email, PC security, parental controls, and online radio services; voice services that comprise unlimited calling in the United States, Canada, Puerto Rico, and Mexico; and IntelligentHome, a security and home administration service.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
